News

Laurent Pharmaceuticals annonces publication of results from Phase 2 study of LAU-7b for the treatment of CF in the Journal of Cystic Fibrosis

18 July 2024

Laurent Pharmaceuticals, Inc., a Montreal-based biopharmaceutical company, today announced the publication in the peer-reviewed Journal of Cystic Fibrosis of previously disclosed results from...

Read More

Laurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference

13 May 2024

Laurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference, May 17-22, San Diego, CA, USA

Read More

EVENTS

Laurent Pharmaceuticals presents data with LAU-7b in Idiopathic Pulmonary Fibrosis at the 2024 ATS International Conference, May 17-22, San Diego, CA, USA
read more
Laurent Pharma to participate to BIO International Convention,  June 3-6 2024, San Diego, CA, USA
read more

Laurent Pharma to participate to BIO International Convention, June 5-8, 2023, Boston, MA

read more
Laurent Pharma to participate to BIO International Convention, June 13-16, 2022 – San Diego, CA
read more
Laurent Pharma to participate to BIO-Europe Spring, March 28-31, 2022
read more